Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Heiss

Showing results (461-470 of 483) with videos related to

Pageof 49
Sort By:
Annals of Neurology|December 19, 2003
Insertion of mutant proteolipid protein results in missorting of myelin proteinsCatherine Vaurs-Barriere, Kondi Wong, Thais D Weibel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2003
PET-based molecular imaging in neuroscienceA H Jacobs, H Li, A Winkeler, et al.
Frontiers in Oncology|August 19, 2022
Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in <i>PMS2</i>Mythili Merchant, Margarita Raygada, Ying Pang, et al.
The Journal of Clinical Investigation|February 7, 2018
Pain control through selective chemo-axotomy of centrally projecting TRPV1+ sensory neuronsMatthew R Sapio, John K Neubert, Danielle M LaPaglia, et al.
Neurology. Genetics|April 28, 2020
Neuraxial dysraphism in <i>EPAS1-</i>associated syndrome due to improper mesenchymal transitionJared S Rosenblum, Anthony J Cappadona, Davis P Argersinger, et al.
Plos One|June 15, 2007
Switching on the lights for gene therapyAlexandra Winkeler, Miguel Sena-Esteves, Leonie E M Paulis, et al.
Neuroimage|February 13, 2010
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Babak Kateb, Katherine Chiu, Keith L Black, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 8, 2024
Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's DiseaseJohn D Heiss, Abhik Ray-Chaudhury, David E Kleiner, et al.
Cancers|May 11, 2024
Antiretroviral Drug Repositioning for GlioblastomaSarah R Rivas, Mynor J Mendez Valdez, Jay S Chandar, et al.
Neuro-Oncology Advances|July 25, 2022
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinibYeshavanth Kumar Banasavadi-Siddegowda, Sriya Namagiri, Yoshihiro Otani, et al.
Pageof 49

Showing results (461-470 of 483) with videos related to

Sort By:
Pageof 49
Annals of Neurology|December 19, 2003
Insertion of mutant proteolipid protein results in missorting of myelin proteinsCatherine Vaurs-Barriere, Kondi Wong, Thais D Weibel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 24, 2003
PET-based molecular imaging in neuroscienceA H Jacobs, H Li, A Winkeler, et al.
Frontiers in Oncology|August 19, 2022
Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in <i>PMS2</i>Mythili Merchant, Margarita Raygada, Ying Pang, et al.
The Journal of Clinical Investigation|February 7, 2018
Pain control through selective chemo-axotomy of centrally projecting TRPV1+ sensory neuronsMatthew R Sapio, John K Neubert, Danielle M LaPaglia, et al.
Neurology. Genetics|April 28, 2020
Neuraxial dysraphism in <i>EPAS1-</i>associated syndrome due to improper mesenchymal transitionJared S Rosenblum, Anthony J Cappadona, Davis P Argersinger, et al.
Plos One|June 15, 2007
Switching on the lights for gene therapyAlexandra Winkeler, Miguel Sena-Esteves, Leonie E M Paulis, et al.
Neuroimage|February 13, 2010
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Babak Kateb, Katherine Chiu, Keith L Black, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 8, 2024
Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's DiseaseJohn D Heiss, Abhik Ray-Chaudhury, David E Kleiner, et al.
Cancers|May 11, 2024
Antiretroviral Drug Repositioning for GlioblastomaSarah R Rivas, Mynor J Mendez Valdez, Jay S Chandar, et al.
Neuro-Oncology Advances|July 25, 2022
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinibYeshavanth Kumar Banasavadi-Siddegowda, Sriya Namagiri, Yoshihiro Otani, et al.
Pageof 49